Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Vague or promotional

Rules 1.1.0 · as of 14 Sep 2026

Quote

Vague or promotional

“Looking at atai's valuation, I have the feeling investors assign zero value to those two late-stage programs (and atai's other 5 clinical stage assets for that matter) at the moment; however, I personally believe these 2 non-psychedelic drugs are "gems within a goldmine".”
· 14 reasons why I am increasing my stake in atai Life Sciences · own post

Angermayer says the two named atai programs RL-007 (Phase 2b, cognitive impairment in schizophrenia) and GRX-917 (ready for Phase 2, anxiety) are undervalued gems, an implicit claim that their trials will deliver.

No entity, observable event, benchmark or threshold can be written from the text and its immediate context. Slogans ('game changer', 'once-in-a-lifetime opportunity', 'favourite stock') and quantifiers with no countable set ('more', 'first', 'all') without a defined set.